BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16092117)

  • 1. Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease.
    Walshe JM
    Mov Disord; 2005 Dec; 20(12):1658-61. PubMed ID: 16092117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors affecting the concentration of serum ceruloplasmin in Wilson-Konovalov disease].
    Mzhel'skaia TI; Ivanova-Smolenskaia IA; Korobova NV
    Vopr Med Khim; 1994; 40(6):48-53. PubMed ID: 7618303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
    Walshe JM;
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):115-21. PubMed ID: 12662398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of an enzymatic assay for the determination of serum ceruloplasmin.
    Macintyre G; Gutfreund KS; Martin WR; Camicioli R; Cox DW
    J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cause of death in Wilson disease.
    Walshe JM
    Mov Disord; 2007 Nov; 22(15):2216-20. PubMed ID: 17712859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a different caeruloplasmin assay method on the relationship between serum copper and caeruloplasmin.
    Twomey PJ
    Postgrad Med J; 2008 Oct; 84(996):549-51. PubMed ID: 19017841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Wilson' disease: rapid diagnosis and differentiation of heterozygous and homozygous carriers with 64CuCl2 (author's transl)].
    Wesch H; Przuntek H; Feist D
    Dtsch Med Wochenschr; 1980 Apr; 105(14):483-8. PubMed ID: 7363808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is low serum tocopherol in Wilson's disease a significant symptom?
    Sinha S; Christopher R; Arunodaya GR; Prashanth LK; Gopinath G; Swamy HS; Taly AB
    J Neurol Sci; 2005 Feb; 228(2):121-3. PubMed ID: 15694191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of copper in serum and urine of hepatolenticular degeneration patient and their clinic meaning].
    Deng SL; Li XF; Guo XL
    Guang Pu Xue Yu Guang Pu Fen Xi; 2003 Jun; 23(3):576-8. PubMed ID: 12953546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper:caeruloplasmin ratio.
    Twomey PJ; Viljoen A; House IM; Reynolds TM; Wierzbicki AS
    J Clin Pathol; 2007 Apr; 60(4):441-2. PubMed ID: 17405985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease.
    Duncan A; Yacoubian C; Beetham R; Catchpole A; Bullock D
    Ann Clin Biochem; 2017 Nov; 54(6):649-654. PubMed ID: 27742851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilson disease in children: analysis of 57 cases.
    Manolaki N; Nikolopoulou G; Daikos GL; Panagiotakaki E; Tzetis M; Roma E; Kanavakis E; Syriopoulou VP
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):72-7. PubMed ID: 19172127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid diagnosis of Wilson disease in acute liver failure: no more waiting for the ceruloplasmin level?
    O'Brien A; Williams R
    Hepatology; 2008 Oct; 48(4):1030-2. PubMed ID: 18821595
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum nitric oxide levels in children with Wilson's disease.
    Selimoglu MA; Ertekin V; Turkan Y; Akcay F
    Int J Clin Pract; 2007 Sep; 61(9):1530-4. PubMed ID: 17535304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of mass infant screening for Wilson disease by urinary ceruloplasmin.
    Kinoshita Y; Yamakami Y; Mori Y; Haruki E; Kikuchi N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():149-50. PubMed ID: 11400755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation.
    Yoshitoshi EY; Takada Y; Oike F; Sakamoto S; Ogawa K; Kanazawa H; Ogura Y; Okamoto S; Haga H; Ueda M; Egawa H; Kasahara M; Tanaka K; Uemoto S
    Transplantation; 2009 Jan; 87(2):261-7. PubMed ID: 19155982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution to the data on copper concentration in blood and urine in patients with Wilson's disease and in normal subjects.
    Lech T; Sadlik JK
    Biol Trace Elem Res; 2007 Jul; 118(1):16-20. PubMed ID: 17848726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V; Trevisan CP; D'IncĂ  R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
    J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroradiological findings in 2 cases of Wilson disease with neurological involvement].
    Troncoso M; Badilla L; Bravo E; Miranda M; Gajewski C; Barrios A; Villagra R
    Rev Med Chil; 1998 Jan; 126(1):81-7. PubMed ID: 9629758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.